Source: Annual Congress 2013 –Asthma at the bedside
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Corlateanu, V. Botnaru, A. Procoava, O. Corlateanu (Chisinau, Republic Of Moldova). Analysis of the cost-effectiveness of monotherapy versus fixed dose combination treatment of asthma in Republic of Moldova. Eur Respir J 2013; 42: Suppl. 57, 2119

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of switching from brand to generic asthma medications Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Availability and compliance to basic therapy of bronchial asthma in rural region of Kazakhstan Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Asthma medication use in the general population of West Sweden Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Current and future costs of asthma in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Consumption of asthma and allergy drugs in Finland Source: International Congress 2016 – Asthma management Year: 2016 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Parameters influencing the participation in an asthma education course for adult asthma patients – Results from the disease management program bronchial asthma in Germany (North Rhine Region) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Cost of asthma in patients treated with national asthma guideline in Turkey Source: Eur Respir J 2003; 22: Suppl. 45, 481s Year: 2003 Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Trends in diagnosis and long-term treatment of patients with asthma in primary health care facilities (1998-2011) in Saint-Petersburg, Russia Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Prescription patterns and treatment adherence of asthma controller therapy in children in a Dutch primary care database Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Hospitalized adult asthmatics after 10 years of a national program in Chile; the study group of difficult asthma GRADI Source: Annual Congress 2013 –Asthma Year: 2013 A survey of the perception of asthma by primary care physicians in Republic of Moldova Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA Source: International Congress 2014 – Paediatric asthma: what is new for the clinician? Year: 2014 Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Treatment effectiveness of TB patients from different groups of population in Moscow Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015 COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013